Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01003496 · ClinicalTrials.gov registry record · Phase 3
Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial
A Phase 3 study, sponsored by Wright State University.
- Completed
- Registry status
- Phase 3
- Development phase
- 204
- Enrollment target
NCT01003496: Completed Phase 3 study, sponsored by Wright State University.
NCT01003496 is a Phase 3 study that has completed, run by Wright State University. The registered enrollment target is 204 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01003496, a Phase 3 study, has completed, sponsored by Wright State University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 204 participants
- Enrollment target
Study Summary
The purpose of this 2 year study is to conduct a fully powered effectiveness trial comparing recovery trajectories of 200 drug dependent adults (the subjects) who will be randomly assigned to Treatment as Usual (TAU) or TAU + Long-Term Recovery Management (LTRM).
Interventions
- BEHAVIORAL Treatment as Usual (TAU)
- BEHAVIORAL TAU + Long-Term Recovery Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2009-11-05 |
| Est. Completion | 2011-07-27 |
| Phase | Phase 3 |
What the finished NCT01003496 record still lists
NCT01003496 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT01003496 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01003496 about?
NCT01003496 is a clinical study titled "Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial". The purpose of this 2 year study is to conduct a fully powered effectiveness trial comparing recovery trajectories of 200 drug dependent adults (the subjects) who will be randomly assigned to Treatment as Usual (TAU) or TAU + Long-Term Recovery Management (LTRM).
What is the current status of trial NCT01003496?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 204 participants. The study started on 2009-11-05. Estimated completion is 2011-07-27.
What interventions are being tested in trial NCT01003496?
The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), TAU + Long-Term Recovery Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT01003496?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01003496's enrollment target sits among peer trials
204 1352nd of 2000 higher than 649 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI